HK1051315A1 - 阿扑嗎啡的口服黏膜劑量形式 - Google Patents

阿扑嗎啡的口服黏膜劑量形式

Info

Publication number
HK1051315A1
HK1051315A1 HK03101912.0A HK03101912A HK1051315A1 HK 1051315 A1 HK1051315 A1 HK 1051315A1 HK 03101912 A HK03101912 A HK 03101912A HK 1051315 A1 HK1051315 A1 HK 1051315A1
Authority
HK
Hong Kong
Prior art keywords
apomorphine
dosage forms
oral mucosal
mucosal dosage
oral
Prior art date
Application number
HK03101912.0A
Other languages
English (en)
Inventor
E Stach Paul
W Davis Craig
A Sison Raymundo
k mansfield Robert
D Bollinger John
K Gupta Pramod
Original Assignee
Tap Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Holdings Inc filed Critical Tap Holdings Inc
Publication of HK1051315A1 publication Critical patent/HK1051315A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HK03101912.0A 1999-12-30 2003-03-14 阿扑嗎啡的口服黏膜劑量形式 HK1051315A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47584499A 1999-12-30 1999-12-30
PCT/US2000/034548 WO2001049292A1 (en) 1999-12-30 2000-12-19 Oral mucosal dosage forms of apomorphine

Publications (1)

Publication Number Publication Date
HK1051315A1 true HK1051315A1 (zh) 2003-08-01

Family

ID=23889387

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101912.0A HK1051315A1 (zh) 1999-12-30 2003-03-14 阿扑嗎啡的口服黏膜劑量形式

Country Status (14)

Country Link
EP (1) EP1242088A1 (zh)
JP (1) JP2004501065A (zh)
CN (1) CN1414853A (zh)
AU (1) AU2440901A (zh)
BR (1) BR0012822A (zh)
CA (1) CA2394297A1 (zh)
CZ (1) CZ20022245A3 (zh)
HK (1) HK1051315A1 (zh)
HU (1) HUP0400495A3 (zh)
IL (1) IL150034A0 (zh)
MX (1) MXPA02006034A (zh)
NO (1) NO20023190L (zh)
PL (1) PL366204A1 (zh)
WO (1) WO2001049292A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202365D0 (sv) 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
JP5283334B2 (ja) * 2003-01-24 2013-09-04 マグル ホールディング エービー 経粘膜伝達用組成物材料
CA2562391A1 (en) * 2004-04-14 2005-10-27 Takeda Pharmaceutical Company Limited Solid pharmaceutical preparation
GB0509317D0 (en) * 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine
PL2952191T3 (pl) * 2009-06-12 2019-02-28 Sunovion Pharmaceuticals Inc. Apomorfina w postaci do podawania podjęzykowego
WO2020243538A1 (en) * 2019-05-31 2020-12-03 Primo Pharmatech Llc Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2239369T3 (es) * 1993-03-26 2005-09-16 Franciscus Wilhelmus Henricus Maria Merkus Composiciones farmaceuticas para administracion intranasal de dihidroergotamina.
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

Also Published As

Publication number Publication date
MXPA02006034A (es) 2004-08-23
CN1414853A (zh) 2003-04-30
NO20023190D0 (no) 2002-07-01
JP2004501065A (ja) 2004-01-15
AU2440901A (en) 2001-07-16
EP1242088A1 (en) 2002-09-25
NO20023190L (no) 2002-08-29
HUP0400495A3 (en) 2007-05-02
PL366204A1 (en) 2005-01-24
HUP0400495A2 (hu) 2004-06-28
WO2001049292A1 (en) 2001-07-12
CZ20022245A3 (cs) 2002-10-16
CA2394297A1 (en) 2001-07-12
IL150034A0 (en) 2002-12-01
BR0012822A (pt) 2004-03-09

Similar Documents

Publication Publication Date Title
HUP0203204A3 (en) Oral dosage forms
EG23943A (en) Flash-melt oral dosage formulation
HK1090840A1 (en) Extended release oral dosage composition
AU6089200A (en) Rapid immediate release oral dosage form
EG23759A (en) Stable extended release oral dosage composition
ZA200202480B (en) Oral dosage forms.
AU1998200A (en) Multiparticulate oral dosage forms
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
AU2003238670A8 (en) Fast disintegrating oral dosage forms
IL166337A0 (en) Oral administration of calctionin
HUP0500638A2 (en) Flashmelt oral dosage formulation
PL340456A1 (en) Novel oral dosage form of carvedilol
IL150034A0 (en) Oral mucosal dosage forms of apomorphine
HUP0201667A2 (en) Oral form of administration
GB9923045D0 (en) New oral formulations
PL352062A1 (en) Oral solution of prucalopride
HUP0401599A3 (en) Extended release oral dosage form
EP1210935A4 (en) DRUGS FOR ORAL USE
HK1047232A1 (zh) 口服劑型
GB9925069D0 (en) Oral dosage form
IL132006A0 (en) Stable pharmaceuticl oral dosage forms
GB0014497D0 (en) Oral dosage form
GB9911839D0 (en) Invention related to oral hygiene
GB0030587D0 (en) Oral administration of beneficial substances
PL341178A1 (en) Oral pharmaceutical dosage forms